Literature DB >> 16716527

Sensory system-predominant distribution of leukotriene A4 hydrolase and its colocalization with calretinin in the mouse nervous system.

Y Chiba1, A Shimada2, M Satoh3, Y Saitoh1, N Kawamura1, A Hanai1, H Keino1, Y Ide4, T Shimizu5, M Hosokawa1.   

Abstract

Leukotriene B4 is a potent lipid mediator, which has been identified as a potent proinflammatory and immunomodulatory compound. Although there has been robust evidence indicating that leukotriene B4 is synthesized in the normal brain, detailed distribution and its functions in the nervous system have been unclear. To obtain insight into the possible neural function of leukotriene B4, we examined the immunohistochemical distribution of leukotriene A4 hydrolase, an enzyme catalyzing the final and committed step in leukotriene B4 biosynthesis, in the mouse nervous system. Immunoreactivity for leukotriene A4 hydrolase showed widespread distribution with preference to the sensory-associated structures; i.e. neurons in the olfactory epithelium and vomeronasal organ, olfactory glomeruli, possibly amacrine cells, neurons in the ganglion cell layer and three bands in the inner plexiform layer of the retina, axons in the optic nerve and tract up to the superior colliculus, inner and outer hair cells and the spiral ganglion cells in the cochlea, vestibulocochlear nerve bundle, spinal trigeminal tract, and lamina II of the spinal cord. Double immunofluorescence staining demonstrated that most of the leukotriene A4-hydrolase-immunopositive neurons coexpressed calretinin, a calcium-binding protein in neurons. The ubiquitous distribution of leukotriene A4 hydrolase was in sharp contrast with the distribution of leukotriene C4 synthase [Shimada A, Satoh M, Chiba Y, Saitoh Y, Kawamura N, Keino H, Hosokawa M, Shimizu T (2005) Highly selective localization of leukotriene C4 synthase in hypothalamic and extrahypothalamic vasopressin systems of mouse brain. Neuroscience 131:683-689] which was confined to the hypothalamic and extrahypothalamic vasopressinergic neurons. These results suggest that leukotriene B4 may exert some neuromodulatory function mainly in the sensory nervous system, in concert with calretinin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716527     DOI: 10.1016/j.neuroscience.2006.04.012

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Sex-specific association of depression and a haplotype in leukotriene A4 hydrolase gene.

Authors:  Jinying Zhao; Arshed A Quyyumi; Riyaz Patel; A Maziar Zafari; Emir Veledar; Stephen Onufrak; Lucy H Shallenberger; Linda Jones; Viola Vaccarino
Journal:  Psychosom Med       Date:  2009-07-21       Impact factor: 4.312

2.  Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.

Authors:  Matthew Birnie; Ryan Morrison; Ramatoulie Camara; Kenneth I Strauss
Journal:  BMC Genomics       Date:  2013-05-04       Impact factor: 3.969

3.  Leukotriene enhances NMDA-induced inward currents in dorsal horn neurons of the rat spinal cord after peripheral nerve injury.

Authors:  Yasukuni Kiyoyuki; Wataru Taniguchi; Masamichi Okubo; Hiroki Yamanaka; Kimiko Kobayashi; Naoko Nishio; Terumasa Nakatsuka; Koichi Noguchi
Journal:  Mol Pain       Date:  2015-09-09       Impact factor: 3.395

4.  The absence of the leukotriene B4 receptor BLT1 attenuates peripheral inflammation and spinal nociceptive processing following intraplantar formalin injury.

Authors:  Miho Asahara; Nobuko Ito; Takehiko Yokomizo; Motonao Nakamura; Takao Shimizu; Yoshitsugu Yamada
Journal:  Mol Pain       Date:  2015-03-12       Impact factor: 3.395

5.  Identification of key lipid metabolites during metabolic dysregulation in the diabetic retinopathy disease mouse model and efficacy of Keluoxin capsule using an UHPLC-MS-based non-targeted lipidomics approach.

Authors:  Nan Ge; Ling Kong; Ai-Hua Zhang; Ye Sun; Man-Qian Zhao; Bo Zhang; Lei Xu; Xiao Ke; Hui Sun; Xi-Jun Wang
Journal:  RSC Adv       Date:  2021-02-01       Impact factor: 3.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.